Abstract
Background: Solid organ transplant (SOT) survival rates have improved with advances in immunosuppressive medications. Chronic immunosuppressive exposure, however, increases the risk of developing malignancies due to the loss of immune surveillance and/or the carcinogenic effects of these medications. Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic lesions that carry malignant potential. The long-term prospective for malignant transformation of IPMN in the setting of chronic immunosuppressive therapy is unclear. In this study, we aim to evaluate the natural history of IPMNs in immunosuppressed transplant patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
